The nation’s leading public health agency, the Centers for Disease Control and Prevention, faces an extended period without a permanent leader. More than seven months after Susan Monarez’s contentious firing, President Donald Trump has yet to nominate a replacement, raising concerns among public health experts about the agency’s stability and direction. The lack of a Senate-confirmed director at the CDC is particularly noteworthy given the ongoing require for vigilance against emerging infectious diseases and the agency’s crucial role in public health preparedness.
Monarez’s tenure as CDC director was remarkably brief – just 28 days. She was ousted in August 2025 following a policy dispute with Health and Human Services Secretary Robert F. Kennedy Jr. Over vaccine policy, a move that prompted the resignations of three other top CDC officials, according to reporting from STAT News and USA Today. Monarez herself contested her termination, arguing that only President Trump had the authority to remove a Senate-confirmed appointee.
A Disagreement Over Vaccine Policy
The core of the conflict centered on Kennedy Jr.’s approach to vaccine recommendations. Dr. Monarez testified to a Senate committee in September 2025 that she was fired for refusing to approve changes to vaccine policy “regardless of the scientific evidence,” as reported by the BBC. She likewise stated that Kennedy Jr. Requested she dismiss career officials responsible for vaccine policy “without cause.” Kennedy Jr. Reportedly demanded that Monarez approve every recommendation from the Advisory Committee on Immunization Practices, despite having dismissed the committee’s full membership and appointed new members in June 2025.
Kennedy Jr. Has previously denied that Monarez was asked to sign off on vaccine recommendations lacking a scientific basis. However, Monarez’s testimony paints a picture of a significant clash over the agency’s scientific independence and its commitment to evidence-based policymaking. She further alleged that Kennedy Jr. Referred to CDC staff as “horrible people” and the agency itself as “corrupt.”
The Risk of Prolonged Leadership Vacuum
The absence of a permanent director is creating uncertainty within the CDC and raising questions about the agency’s ability to effectively respond to public health challenges. Samuel Bagenstos, a professor of law and social policy at the University of Michigan, expressed concern that the CDC may remain without a presidentially appointed and Senate-confirmed director for the remainder of the Trump administration. “I think there’s a high likelihood that the CDC will not have a presidentially appointed and a confirmed director in [the remainder of] this administration,” Bagenstos told STAT News.
This leadership vacuum comes at a time when the CDC is facing numerous complex issues, including ongoing monitoring of COVID-19 variants, addressing the rise of antimicrobial resistance, and preparing for future pandemics. Without a stable and experienced leader at the helm, the agency’s ability to effectively address these challenges could be compromised. The situation also raises concerns about potential political interference in the agency’s scientific work.
Previous Leadership and the Interim Role
Prior to Monarez’s brief appointment, the CDC had been led by acting directors following the departure of Rochelle Walensky in 2024. Jim O’Neill served as the acting director before Monarez, but his tenure also faced scrutiny. STAT News reported in December 2025 that O’Neill’s exit highlighted the agency’s broader lack of consistent leadership.
The reliance on acting directors can create instability and hinder long-term planning. Without a permanent leader, the agency may struggle to implement new initiatives or respond effectively to emerging threats. The extended period without a confirmed director also raises questions about the administration’s commitment to public health.
What’s Next for the CDC?
As of February 15, 2026, the White House has not announced any plans to nominate a new CDC director. The agency continues to operate under interim leadership, relying on experienced career staff to maintain essential functions. The next key development will be any indication from the White House regarding a potential nomination. Public health advocates and experts will be closely watching for any signs of movement on this front.
The ongoing leadership uncertainty at the CDC underscores the importance of protecting the agency’s scientific independence and ensuring that it has the resources and leadership it needs to effectively protect the nation’s health. The situation serves as a reminder of the critical role that the CDC plays in safeguarding public health and the potential consequences of political interference in its work.
Disclaimer: This article provides information for general knowledge and informational purposes only, and does not constitute medical advice. It is essential to consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.
What are your thoughts on the leadership situation at the CDC? Share your comments below, and please share this article with your network.
